Clinical trial · no report yet · Phase not applicable
OLIGOMA
Metastases-directed Radiotherapy in Addition to Standard Systemic Therapy in Patients With Oligometastatic Breast Cancer
- NCT04495309 ↗
- Completed
- University Hospital Schleswig-Holstein
- Standard
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Preliminary discovery
Commentary in our index that names this trial so far
Podcasts, YouTube videos and X posts we have indexed. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build.
| Channel | Found | |
|---|---|---|
| X threads | 18 |
The trial
ClinicalTrials.gov- Official title
- Effectiveness and Tolerability of Metastases-directed Radiotherapy in Addition to Standard Systemic Therapy in Patients With Oligometastatic Breast Cancer: A Randomized Controlled Multinational and Multicenter Clinical Trial
- Phase
- Phase not applicable
- Status
- Completed
- Conditions
- Metastatic Breast Cancer
- Interventions
- Metastases-directed Radiotherapy
- Arms
- Standard · No intervention
- Experimental · Experimental
- Enrollment
- 87
- Primary outcomes
- First co-primary outcome measure is progression-free survival (PFS)
- Second co-primary outcome measure is quality of life
- Sponsor
- University Hospital Schleswig-Holstein
- Start
- Mar 5, 2021
- Primary completion
- Jun 3, 2025
- Results posted
- No
- Registry record
- NCT04495309 · updated Feb 27, 2026
Publications
linked from the registry- Krug D, Vonthein R, Illen A, Olbrich D, Barkhausen J, Richter J, Klapper W, Schmalz C, Rody A, Maass N, Bauerschlag D, Hessler N, Konig IR, Dellas K, Dunst J. Metastases-directed Radiotherapy in Addition to Standard Systemic Therapy in Patients with Oligometastatic Breast Cancer: Study protocol for a randomized controlled multi-national and multi-center clinical trial (OLIGOMA). Clin Transl Radiat Oncol. 2021 Apr 5;28:90-96. doi: 10.1016/j.ctro.2021.03.012. eCollection 2021 May. PubMed 33912695